Paediatric travel medicine: vaccines and medications

Mike Starr1

  • 1The Royal Children's Hospital Melbourne, Parkville, Victoria, Australia. mike.starr@rch.org.au

Insights

Children traveling abroad are more prone to common infections than tropical diseases. Malaria and tuberculosis are exceptions, posing greater risks to kids, alongside common travelers' diarrhea.

Area of Science:

  • Pediatric Travel Medicine
  • Infectious Diseases in Children
  • Global Health

Background:

  • Children face unique risks in travel medicine, often requiring tailored advice.
  • Common infections are more prevalent in traveling children than rare tropical diseases.
  • Malaria and tuberculosis present significant, severe risks for pediatric travelers.

Purpose of the Study:

  • To review essential vaccines and medications for children traveling internationally.
  • To highlight routine immunizations and travel-specific vaccinations for pediatric populations.
  • To discuss the prevention and management of malaria and travelers' diarrhea in children.

Main Methods:

  • Literature review of pediatric travel medicine guidelines.
  • Analysis of vaccine recommendations for routine and travel-specific immunization.
  • Synthesis of information on malaria and travelers' diarrhea in pediatric travelers.

Main Results:

  • Most travel-related illnesses in children are common infections, not exotic diseases.
  • Malaria and tuberculosis are notably more frequent and severe in pediatric travelers.
  • Travelers' diarrhea remains the most common illness encountered by international travelers.

Conclusions:

  • Travel medicine for children requires individualized assessment, balancing common risks with specific threats like malaria.
  • Comprehensive review of pediatric travel health, including immunizations and common illnesses, is crucial for safe international travel.
  • Vaccinations and appropriate medical advice are key to preventing and managing travel-related illnesses in children.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Vaccinations01:51

Vaccinations

Overview
Microorganisms in Medicine and Therapeutics01:29

Microorganisms in Medicine and Therapeutics

Microorganisms play a fundamental role in vaccine development, gene therapy, and therapeutic production. Their biological properties are harnessed to advance medicine and public health. Beyond immunization, microorganisms contribute to gut health, antibiotic synthesis, and genetic disease treatment.Live Attenuated and Inactivated VaccinesLive attenuated vaccines, such as the measles, mumps, and rubella (MMR) vaccine, utilize weakened forms of pathogens to closely resemble natural infections.
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...